Stockholders' Equity (Deficit) (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Stock Option Activity under the Plans

Stock option activity under the Plans for the three months ended March 31, 2022 was as follows:

	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value
Balance—December 31, 2021		23,000,872		$	5.62		6.81	$	436,630
Granted		—			—
Exercised		(1,728,006	)		3.73
Canceled		(360,985	)		6.73
Balance—March 31, 2022		20,911,881		$	5.75		6.62	$	366,105
Options vested		13,445,692		$	3.60		5.82	$	261,336

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

RSU activity during the three months ended March 31, 2022 was as follows:

	Number of Shares			Weighted-Average Grant Fair Value		Aggregate Intrinsic Value
Unvested balance—December 31, 2021		7,387,288		$	29.68	$	180,545
Granted		1,075,008			21.01
Released		(322,335	)		30.81
Forfeited		(198,372	)		31.31
Unvested balance—March 31, 2022		7,941,589		$	28.42	$	182,974

Summary of Stock-Based Compensation Expense in the Consolidated Statements of Operations

Stock-based compensation expense for the three months ended March 31, 2022 and 2021 is classified in the unaudited condensed consolidated statements of operations as follows:

	Three Months Ended March 31,
	2022		2021
Cost of revenue	$	577	$	107
Research and development		9,743		2,028
Sales and marketing		6,274		1,347
General and administrative		5,384		1,802
Total	$	21,978	$	5,284

Summary of Shares of Common Stock Reserved for Future Issuance

The Company’s common stock reserved for future issuance as of March 31, 2022 and December 31, 2021 was as follows:

	March 31, 2022		December 31, 2021
Stock options outstanding		20,911,881		23,000,872
RSUs outstanding		7,941,589		7,387,288
Shares available for future grants		25,030,122		16,905,525
Total shares of common stock reserved		53,883,592		47,293,685